---
schema_version: "secwatch.filing_event.v1"
accession: "0000012208-23-000074"
form_type: "8-K"
ticker: "BIO"
cik: "0000012208"
company_name: "BIO-RAD LABORATORIES, INC."
filed_at: "2023-12-07T23:59:59+00:00"
generated_at: "2026-06-07T16:01:29.810384+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Bio-Rad EVP & President of Clinical Diagnostics Group to resign effective Jan 12, 2024

## Summary
- Dara Grantham Wright notified resignation to pursue another opportunity, effective Jan 12, 2024.
- Wright served as EVP, President of Clinical Diagnostics Group and was a named executive officer.
- Company has initiated a search for her replacement; no successor named yet.

## SEC filing metadata
- accession: 0000012208-23-000074
- form_type: 8-K
- ticker: BIO
- cik: 0000012208
- company_name: BIO-RAD LABORATORIES, INC.
- filed_at: 2023-12-07T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/12208/000001220823000074/0000012208-23-000074-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/12208/000001220823000074/bio-20231204.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000012208-23-000074
- JSON: https://secwatch.observer/filing/0000012208-23-000074.json
- Plain text: https://secwatch.observer/filing/0000012208-23-000074.txt

## Key facts
- Executive change
  Dara Grantham Wright departed as Executive Vice-President and President, Clinical Diagnostics Group at BIO-RAD LABORATORIES, INC..
  - Action: resign
  - Role: Executive Vice-President and President, Clinical Diagnostics Group
  source text: On December 4, 2023, Dara Grantham Wright, the Executive Vice-President and President, Clinical Diagnostics Group, of Bio-Rad Laboratories, Inc. (the “Company”) and a named executive officer of the Company, notified the Company of her plans to resign from the Company to pursue another opportunity, effective at the close of business on January 12, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/12208/000001220823000074/0000012208-23-000074-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.